Skip to content
10-Q

Quarterly Report

Ibere Pharmaceuticals

0001410578-21-000156

← back to feed
Filed
Nov 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Short Term Debt Q3 2021 · Sep 30, 2021 $0
Cash And Equivalents Q3 2021 · Sep 30, 2021 $680.42K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $175.37K
Current Liabilities Q3 2021 · Sep 30, 2021 $290.52K
Current Liabilities Q3 2021 · Dec 31, 2020 $657.13K
Total Liabilities Q3 2021 · Sep 30, 2021 $12.16M
Total Liabilities Q3 2021 · Dec 31, 2020 $657.13K
Current Assets Q3 2021 · Sep 30, 2021 $971.88K
Current Assets Q3 2021 · Dec 31, 2020 $175.37K
Total Assets Q3 2021 · Sep 30, 2021 $138.98M
Total Assets Q3 2021 · Dec 31, 2020 $676.37K